Text this: Tumor marker analyses from the phase III, placebo-controlled, FASTACT-2 study of intercalated erlotinib with gemcitabine/platinum in the first-line treatment of advanced non-small-cell lung cancer

 _    _    __   __    _____    _    _    _____    
| |  | ||  \ \\/ //  / ____|| | || | || |  __ \\  
| |/\| ||   \ ` //  / //---`' | || | || | |  \ || 
|  /\  ||    | ||   \ \\___   | \\_/ || | |__/ || 
|_// \_||    |_||    \_____||  \____//  |_____//  
`-`   `-`    `-`'     `----`    `---`    -----`